Atlas Trials

A Randomized Clinical Trial to Evaluate the Effects of Atorvastatin on Graves' Orbitopathy (GO): the STAGO-2 Study

Clinical trial NCT05049603 · NOT_YET_RECRUITING

Trial details

NCT number
NCT05049603
Sponsor
University of Pisa
Status
NOT_YET_RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Graves' Orbitopathy
Start date
2024-01-01
Primary completion
2025-12-31
Enrollment
102

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.